Led by Andrew Goldberg OBE of UCL and the Royal National Orthopaedic Hospital, this first-in-man pilot study explores the treatment of Achilles Tendinopathy using a culture of expanded autologous mesenchymal stem cells to repair damage. Stems cells will be taken from the patient's own hip, expanded in the laboratory then implanted into the damaged tendon. UCL is one of the few centres in the world developing expertise into the regeneration of tendons using stem cells, as well as translating successful treatments used in horses into humans.
Achilles Tendinopathy causes pain in the heel and affects more than 70,000 people a year in the UK.
Andrew Goldberg OBE, University College London